Supply of care and prevention;Offre de soins et prévention

Presse Medicale

Volumn 31, Issue 4, 2002, Pages 176-185

  Landais, P ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC KIDNEY FAILURE; DIALYSIS; DISEASE COURSE; FRANCE; HEALTH CARE; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION;

DELIVERY OF HEALTH CARE; DISEASE PROGRESSION; FRANCE; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; INFORMATION SYSTEMS; KIDNEY FAILURE, CHRONIC; PREVENTIVE MEDICINE; PUBLIC HEALTH; RISK FACTORS;

EID: 0037006202     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (88)

1. Recueil d'informations sur la prise en charge de l'insuffisance rénale terminale
2. Annual report on management of renal failure in Europe XXVII, 1997
3. The provision of renal replacement therapy for adults in England and Wales: Recent trends and future directions
4. What determines geographical variations in rates of acceptance onto replacement therapy in England?
5. Treatment of end stage renal disease in central and eastern Europe: Overview of current status and future needs
6. Why so much disparity of PD in Europe?
7. Healthcare systems and end-stage renal disease (ESRD) therapies - An international review: Access to ESRD treaments
8. Non-medical factors that impact on ESRD modality selection
9. Access to Whey transplantation: Has the United States eliminated income and raciocal differences?
10. Socio economic status and end-stage renal disease in the United States
11. Racial differences in access to kidney transplantation
12. The impact of comorbid and sociodemographic factors on access to renal transplantation
13. Barriers to cadaveric renal transplantation among blacks, women and the poor
14. Comparisons of treatment costs between dialysis and transplantation
15. Effect of the owership of dialysis facilities on patient's survival and referral for transplantation
16. Population need for renal replacement therapy in Thames region: Ethnic dimension
17. Late referral for maintenance dialysis
18. Late referral to maintenance dialysis: Detrimental consequences
19. Chronic renal failure: Factors influencing nephrology referral
20. Delayed referral for dialysis
21. Bénéfices d'une prise en charge néphrologique précoce au cours de l'insuffisance rénale chronique
22. The medical and economical advantages of early referral of chronic renal failure patients to renal specialists
23. Early referral to the nephrologist and timely initiation of renal replacement therapy: A paradigm shift in the management of patients with chronic renal failure
24. Abysmal prognosis of patients with type 2 diabetes entering dialysis
25. Timing of nephrology referral: Influence on mortality and morbidity
26. Determinants of delayed nephrologist referral in patients with chronic kidney disease
27. Late diagnosis of chronic renal failure and mortality on maintenance dialysis
28. Prevalence, predictors, and consequences of late referral at a tertiary care center
29. The pattern of referral of patients with end-stage renal disease to the nephrologist - A european survey
30. Epidemiology of end-stage renal disease in the Ile-de-France area: A prospective study in 1998
31. An intervention for employment maintenance among blue-collar workers with end-stage renal disease
32. Live and learn: Patients education delays the need to initiate renal replacement therapy in ESR diseases
33. Multidisciplinary predialysis programs: Quantification of their impact on patient outcomes in two Canadian settings
34. The timing of referral of patients with end-stage renal disease
35. The cost of hospitalisations due to hemodialysis access management
36. The medical and economical advantages of early referral of chronic renal failure patients to renal specialists
37. Optimization of pre-ESRD care: The key to improved dialysis outcomes
38. Is 125 lothalamate an ideal marker for glomerular filtration?
39. Management of renal disease and hypertension in insulin dependent diabetes with emphasis on early nephropathy
40. Utility of radioisotopic filtration markers in chronic renal insufficiency: Simultaneous comparison of 1251-Thalamate, 169 Yb-DTPA, 99mTc-DTPA, and inulin
41. Quand commencer la dialyse: Les bases de la décision
42. Dialysis decision making in Canada, the United Kingdom and the United States
43. An evidence-based approach to earlier initiation of dialysis
44. Healthcare systems and end-stage renal disease (ESRD) therapies - An international review: Costs and reimbursement/funding of ESRD therapies
45. L'insuffisance rénale terminale traitée en France - Epidémiologie et système d'information
46. Recueil d'informations sur la prise en charge de l'insuffisance rénale terminale, étude de faisabilité
47. SIMS-REIN. Un système d'information multi-sources pour l'insuffisance rénale terminale
48. Update on organ donation and retrieval in Spain
49. Pour une nouvelle stratégie de prélèvement d'organes: Une priorité de santé publique
50. Organ shortage: A public health crisis. What is the French state doing about it?
51. Organ transplant waiting-list in France
52. Cost-effectiveness studies of renal transplantation
53. Cost-effectiveness of repeat medical procedures: Kidney transplantation as an example
54. Don d'organes en France. Situation actuelle et perspectives
55. Living unrelated donor kidney transplantation
56. From association to causation: Some remarks on the history of statistics
57. Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies, and chronic interstitial nephritides
58. Fibrose interstitielle rénale. Nouveaux concepts physiopathologiques
59. Blood pressure and end-stage renal disease in men
60. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy
61. Blood pressure control, proteinuria, and the progression of renal disease. The modification of diet in renal disease study
62. The effect dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: A meta-analysis
63. Hypertension, hyperlipidemia, and renal damage
64. Risk of end-stage renal disease in diabetes mellitus: A prospective cohort study of men screened for MRFIT
65. Gênes et polycystines dans la polylkystose rénale
66. Genetics of diabetic nephropathy: Evidence for major and minor gene effects
67. Increased frequency of G-protein b3-subunit 825 T allele in dialyzed patients with type 2 diabetes
68. Role of the deletion of polymorphism of the angio-tensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy
69. Factors affecting progression of renal insufficiency
70. L'ochratoxine est-elle néphrotoxique chez l'homme?
71. Rapidly progressive interstitial renal fibrosis in young women: Association with slimming regimen including Chinese herbs
72. A review of epidemiologic studies of non narcotic analgesics and chronic renal disease
73. Analgesic use and chronic renal failure: A critical review of the epidemiologic literature
74. Effects of NSAIDs on the kidney
75. Analgesic nephropathy and the use of nonsteroidal-inflammatory drugs in renal patients: New insight
76. Drug nephrotoxicity: An overview
77. Radiocontrast-induced nephropathy
78. Epidémiologie des néphropathies toxiques
79. Serum creatinine levels in the US population: Third National Health and Nutrition Examination Survey